The Fertility Biochip is an advanced tool that provides a detailed understanding of baseline hormone levels and any imbalances that may be causing adverse effects on a person’s overall health or fertility, enabling the tracking of changes over time.

Our Fertility Biochip can provide a full diagnostic hormone profile which can indicate various conditions such as polycystic ovary syndrome (PCOS), menopause, hormone imbalances affecting ovulation and ovulation indication. For patients going through in vitro fertilisation (IVF), the Fertility Biochip can determine the menstrual cycle stage and response to fertility treatment.

The SHBG Biochip is primarily measured alongside a total testosterone test to estimate the amount of free testosterone in the patients’ blood. In men it is used to look for testosterone deficiency, whereas in women the primary function for a SHBG test would be to investigate excess production of testosterone.

The Testosterone Biochip can be used to aid diagnosis and treatment of conditions such as infertility, primary and secondary hypogonadism, testicular failure, androgen resistance and PCOS.

Anti-Müllerian Hormone (AMH) testing offers critical insights into a woman’s ovarian reserve and egg count. Biochip quantifies the concentration of AMH, a hormone produced by ovarian follicles. Elevated AMH levels indicate a higher ovarian reserve, whereas diminished levels indicate a reduced level. AMH testing can aid clinicians in assessing the body’s responsiveness to ovarian stimulation protocols.

Human Chorionic Gonadotropin (hCG) testing measures the levels of hCG, a hormone produced by the placenta during pregnancy. This hormone is crucial for maintaining pregnancy as it supports the uterine lining and prevents menstruation. Testing for hCG can be used to confirm pregnancy, estimate age of the foetus, identify abnormal pregnancies, and screen for potential miscarriages. Biochip uses serum samples as blood tests are more precise and can detect hCG levels at an early stage after conception.